Lung Cancer Therapeutics Market Trend, Share, Growth, Size, Analysis and Forecast 2032

• Chapter 1. Introduction
  • 1.1. Report description and scope
  • 1.2. Research scope
  • 1.3. Research methodology
    • 1.3.1. Market research process
    • 1.3.2. Market research methodology
•  
• Chapter 2. Executive Summary
  • 2.1. Global Lung Cancer Therapeutics Market Revenue, 2016-2025 (USD Billion)
  • 2.2. Global Lung Cancer Therapeutics Market: Snapshot
•  
• Chapter 3. Lung Cancer Therapeutics Market - Industry Dynamics
  • 3.1. Introduction
  • 3.2. Market drivers
    • 3.2.1. Global Lung Cancer Therapeutics Market Drivers: Impact Analysis
    • 3.2.2. Increasing Prevalence of Lung Cancer
    • 3.2.3. Increasing adoption of targeted therapies
  • 3.3. Market restraints
    • 3.3.1. High capital investments
  • 3.4. Opportunities
    • 3.4.1. Emerging markets
  • 3.5. Porter's Five Forces Analysis
  • 3.6. Market attractiveness analysis
    • 3.6.1. Market attractiveness analysis, by Cancer Type
    • 3.6.2. Market attractiveness analysis, by Treatment
    • 3.6.3. Market attractiveness analysis, by Drug Class
    • 3.6.4. Market attractiveness analysis, by End-User
    • 3.6.5. Market attractiveness analysis, by Distribution Channel
    • 3.6.6. Market attractiveness analysis, by Region
•  
• Chapter 4. Global Lung Cancer Therapeutics Market - Competitive Landscape
  • 4.1. Company Market Share Analysis
    • 4.1.1. Global Lung Cancer Therapeutics Market: Company Market Share, 2018
  • 4.2. Strategic Development
    • 4.2.1. Acquisitions & Mergers
    • 4.2.2. New Product Launch
    • 4.2.3. Agreements, Partnerships, Collaborations, and Joint Ventures
    • 4.2.4. Research and Development and Regional Expansion
•  
• Chapter 5. Global Lung Cancer Therapeutics Market - Cancer Type Analysis
  • 5.1. Global Lung Cancer Therapeutics Market: Cancer Type Overview
    • 5.1.1. Global Lung Cancer Therapeutics Market Share, by Cancer Type, 2018 and 2025
  • 5.2. Non-Small Cell Lung Cancer
    • 5.2.1. Global Lung Cancer Therapeutics Market for Non-Small Cell Lung Cancer, 2016-2025 (USD Billion)
  • 5.3. Small Cell Lung Cancer
    • 5.3.1. Global Lung Cancer Therapeutics Market for Small Cell Lung Cancer, 2016-2025 (USD Billion)
•  
• Chapter 6. Global Lung Cancer Therapeutics Market - Treatment Analysis
  • 6.1. Global Lung Cancer Therapeutics Market: Treatment overview
    • 6.1.1. Global Lung cancer therapeutics Market Share, by Treatment, 2018 and 2025
  • 6.2. Immunotherapy
    • 6.2.1. Global Lung cancer therapeutics market for Immunotherapy, 2016-2025 (USD Billion)
  • 6.3. Chemotherapy
    • 6.3.1. Global Lung cancer therapeutics market for Chemotherapy, 2016-2025 (USD Billion)
  • 6.4. Targeted Therapy
    • 6.4.1. Global Lung cancer therapeutics market for Targeted Therapy, 2016-2025 (USD Billion)
  • 6.5. Radiation Therapy
    • 6.5.1. Global Lung cancer therapeutics market for Radiation Therapy, 2016-2025 (USD Billion)
  • 6.6. Others
    • 6.6.1. Global Lung cancer therapeutics market for Others, 2016-2025 (USD Billion)
•  
• Chapter 7. Global Lung Cancer Therapeutics Market - Drug Class Analysis
  • 7.1. Global Lung Cancer Therapeutics Market: Drug Class Overview
    • 7.1.1. Global Lung cancer therapeutics Market Share, by Drug class, 2018 and 2025
  • 7.2. Antimetabolites
    • 7.2.1. Global Lung cancer therapeutics market for Antimetabolites, 2016-2025 (USD Billion)
  • 7.3. Alkylating Agents
    • 7.3.1. Global Lung cancer therapeutics market for Alkylating Agents, 2016-2025 (USD Billion)
  • 7.4. Mitotic Inhibitors
    • 7.4.1. Global Lung Cancer Therapeutics Market for Mitotic Inhibitors, 2016-2025 (USD Billion)
  • 7.5. EGFR Inhibitors
    • 7.5.1. Global Lung Cancer Therapeutics Market for EGFR Inhibitors, 2016-2025 (USD Billion)
  • 7.6. Multikinase Inhibitors
    • 7.6.1. Global Lung Cancer Therapeutics Market for Multikinase Inhibitors, 2016-2025 (USD Billion)
  • 7.7. Others
    • 7.7.1. Global Lung cancer therapeutics market for Others, 2016-2025 (USD Billion)
•  
• Chapter 8. Global Lung Cancer Therapeutics Market - End-User Analysis
  • 8.1. Global Lung Cancer Therapeutics Market: End-User overview
    • 8.1.1. Global Lung cancer therapeutics Market share, by End-User, 2018 and 2025
  • 8.2. Hospitals
    • 8.2.1. Global Lung Cancer Therapeutics Market for Hospitals, 2016-2025 (USD Billion)
  • 8.3. Homecare
    • 8.3.1. Global Lung Cancer Therapeutics Market for Homecare, 2016-2025 (USD Billion)
  • 8.4. Specialty Clinics
    • 8.4.1. Global Lung Cancer Therapeutics Market for Specialty Clinics, 2016-2025 (USD Billion)
  • 8.5. Others
    • 8.5.1. Global Lung Cancer Therapeutics Market for Others, 2016-2025 (USD Billion)
•  
• Chapter 9. Global Lung Cancer Therapeutics Market - Distribution Channel Analysis
  • 9.1. Global Lung Cancer Therapeutics Market: Distribution Channel overview
    • 9.1.1. Global Lung cancer therapeutics Market share, by Distribution Channel, 2018 and 2025
  • 9.2. Retail Pharmacy
    • 9.2.1. Global Lung Cancer Therapeutics Market for Retail Pharmacy, 2016-2025 (USD Billion)
  • 9.3. Hospital Pharmacy
    • 9.3.1. Global Lung Cancer Therapeutics Market for Hospital Pharmacy, 2016-2025 (USD Billion)
  • 9.4. Internet
    • 9.4.1. Global Lung cancer therapeutics market for Internet, 2016-2025 (USD Billion)
  • 9.5. Others
    • 9.5.1. Global Lung cancer therapeutics market for Others, 2016-2025 (USD Billion)
•  
• Chapter 10. Global Lung Cancer Therapeutics Market - Regional Analysis
  • 10.1. Global Lung Cancer Therapeutics Market: Regional overview
    • 10.1.1. Global Lung cancer therapeutics market share, by Region, 2018 and 2025
  • 10.2. North America
    • 10.2.1. North America Lung cancer therapeutics market revenue, by Cancer Type, 2016-2025 (USD Billion)
    • 10.2.2. North America Lung cancer therapeutics market revenue, by Treatment, 2016-2025 (USD Billion)
    • 10.2.3. North America Lung cancer therapeutics market revenue, by Drug Class, 2016-2025 (USD Billion)
    • 10.2.4. North America Lung cancer therapeutics market revenue, by End-User, 2016-2025 (USD Billion)
    • 10.2.5. North America Lung cancer therapeutics market revenue, by Distribution Channel, 2016-2025 (USD Billion)
    • 10.2.6. The U.S.
      • 10.2.6.1. The U.S. Lung cancer therapeutics market revenue, by Cancer Type, 2016-2025 (USD Billion)
      • 10.2.6.2. The U.S. Lung cancer therapeutics market revenue, by Treatment, 2016-2025 (USD Billion)
      • 10.2.6.3. The U.S. Lung cancer therapeutics market revenue, by Drug Class, 2016-2025 (USD Billion)
      • 10.2.6.4. The U.S. Lung cancer therapeutics market revenue, by End-User, 2016-2025 (USD Billion)
      • 10.2.6.5. The U.S. Lung cancer therapeutics market revenue, by Distribution Channel, 2016-2025 (USD Billion)
    • 10.2.7. Rest of North America
      • 10.2.7.1. Rest of North America Lung cancer therapeutics market revenue, by Cancer Type, 2016-2025 (USD Billion)
      • 10.2.7.2. Rest of North America Lung cancer therapeutics market revenue, by Treatment, 2016-2025 (USD Billion)
      • 10.2.7.3. Rest of North America Lung cancer therapeutics market revenue, by Drug Class, 2016-2025 (USD Billion)
      • 10.2.7.4. Rest of North America Lung cancer therapeutics market revenue, by End-User, 2016-2025 (USD Billion)
      • 10.2.7.5. Rest of North America Lung cancer therapeutics market revenue, by Distribution Channel, 2016-2025 (USD Billion)
  • 10.3. Europe
    • 10.3.1. Europe Lung cancer therapeutics market revenue, by Cancer Type, 2016-2025 (USD Billion)
    • 10.3.2. Europe Lung cancer therapeutics market revenue, by Treatment, 2016-2025 (USD Billion)
    • 10.3.3. Europe Lung cancer therapeutics market revenue, by Drug Class, 2016-2025 (USD Billion)
    • 10.3.4. Europe Lung cancer therapeutics market revenue, by End-User, 2016-2025 (USD Billion)
    • 10.3.5. Europe Lung cancer therapeutics market revenue, by Distribution Channel, 2016-2025 (USD Billion)
    • 10.3.6. Germany
      • 10.3.6.1. Germany Lung cancer therapeutics market revenue, by Cancer Type, 2016-2025 (USD Billion)
      • 10.3.6.2. Germany Lung cancer therapeutics market revenue, by Treatment, 2016-2025 (USD Billion)
      • 10.3.6.3. Germany Lung cancer therapeutics market revenue, by Drug Class, 2016-2025 (USD Billion)
      • 10.3.6.4. Germany Lung cancer therapeutics market revenue, by End-User, 2016-2025 (USD Billion)
      • 10.3.6.5. Germany Lung cancer therapeutics market revenue, by Distribution Channel, 2016-2025 (USD Billion)
    • 10.3.7. The U.K.
      • 10.3.7.1. U.K. Lung cancer therapeutics market revenue, by Cancer Type, 2016-2025 (USD Billion)
      • 10.3.7.2. U.K. Lung cancer therapeutics market revenue, by Treatment, 2016-2025 (USD Billion)
      • 10.3.7.3. U.K. Lung cancer therapeutics market revenue, by Drug Class, 2016-2025 (USD Billion)
      • 10.3.7.4. U.K. Lung cancer therapeutics market revenue, by End-User, 2016-2025 (USD Billion)
      • 10.3.7.5. U.K. Lung cancer therapeutics market revenue, by Distribution Channel, 2016-2025 (USD Billion)
    • 10.3.8. France
      • 10.3.8.1. France Lung cancer therapeutics market revenue, by Cancer Type, 2016-2025 (USD Billion)
      • 10.3.8.2. France Lung cancer therapeutics market revenue, by Treatment, 2016-2025 (USD Billion)
      • 10.3.8.3. France Lung cancer therapeutics market revenue, by Drug Class, 2016-2025 (USD Billion)
      • 10.3.8.4. France Lung cancer therapeutics market revenue, by End-User, 2016-2025 (USD Billion)
      • 10.3.8.5. France Lung cancer therapeutics market revenue, by Distribution Channel, 2016-2025 (USD Billion)
    • 10.3.9. Rest of Europe
      • 10.3.9.1. Rest of Europe Lung cancer therapeutics market revenue, by Cancer Type, 2016-2025 (USD Billion)
      • 10.3.9.2. Rest of Europe Lung cancer therapeutics market revenue, by Treatment, 2016-2025 (USD Billion)
      • 10.3.9.3. Rest of Europe Lung cancer therapeutics market revenue, by Drug Class, 2016-2025 (USD Billion)
      • 10.3.9.4. Rest of Europe Lung cancer therapeutics market End-User, by End-User, 2016-2025 (USD Billion)
      • 10.3.9.5. Rest of Europe Lung cancer therapeutics market revenue, by Distribution Channel, 2016-2025 (USD Billion)
  • 10.4. Asia Pacific
    • 10.4.1. Asia Pacific Lung cancer therapeutics market revenue, by Cancer Type, 2016-2025 (USD Billion)
    • 10.4.2. Asia Pacific Lung cancer therapeutics market revenue, by Treatment, 2016-2025 (USD Billion)
    • 10.4.3. Asia Pacific Lung cancer therapeutics market revenue, by Drug Class, 2016-2025 (USD Billion)
    • 10.4.4. Asia Pacific Lung cancer therapeutics market revenue, by End-User, 2016-2025 (USD Billion)
    • 10.4.5. Asia Pacific Lung cancer therapeutics market revenue, by Distribution Channel, 2016-2025 (USD Billion)
    • 10.4.6. China
      • 10.4.6.1. China Lung cancer therapeutics market revenue, by Cancer Type, 2016-2025 (USD Billion)
      • 10.4.6.2. China Lung cancer therapeutics market revenue, by Treatment, 2016-2025 (USD Billion)
      • 10.4.6.3. China Lung cancer therapeutics market revenue, by Drug Class, 2016-2025 (USD Billion)
      • 10.4.6.4. China Lung cancer therapeutics market revenue, by End-User, 2016-2025 (USD Billion)
      • 10.4.6.5. China Lung cancer therapeutics market revenue, by Distribution Channel, 2016-2025 (USD Billion)
    • 10.4.7. Japan
      • 10.4.7.1. Japan Lung cancer therapeutics market revenue, by Cancer Type, 2016-2025 (USD Billion)
      • 10.4.7.2. Japan Lung cancer therapeutics market revenue, by Treatment, 2016-2025 (USD Billion)
      • 10.4.7.3. Japan Lung cancer therapeutics market revenue, by Drug Class, 2016-2025 (USD Billion)
      • 10.4.7.4. Japan Lung cancer therapeutics market revenue, by End-User, 2016-2025 (USD Billion)
      • 10.4.7.5. Japan Lung cancer therapeutics market revenue, by Distribution Channel, 2016-2025 (USD Billion)
    • 10.4.8. India
      • 10.4.8.1. India Lung cancer therapeutics market revenue, by Cancer Type, 2016-2025 (USD Billion)
      • 10.4.8.2. India Lung cancer therapeutics market revenue, by Treatment, 2016-2025 (USD Billion)
      • 10.4.8.3. India Lung cancer therapeutics market revenue, by Drug Class, 2016-2025 (USD Billion)
      • 10.4.8.4. India Lung cancer therapeutics market revenue, by End-User, 2016-2025 (USD Billion)
      • 10.4.8.5. India Lung cancer therapeutics market revenue, by Distribution Channel, 2016-2025 (USD Billion)
    • 10.4.9. Rest of Asia Pacific
      • 10.4.9.1. Rest of Asia Pacific Lung cancer therapeutics market revenue, by Cancer Type, 2016-2025 (USD Billion)
      • 10.4.9.2. Rest of Asia Pacific Lung cancer therapeutics market revenue, by Treatment, 2016-2025 (USD Billion)
      • 10.4.9.3. Rest of Asia Pacific Lung cancer therapeutics market revenue, by Drug Class, 2016-2025 (USD Billion)
      • 10.4.9.4. Rest of Asia Pacific Lung cancer therapeutics market revenue, by End-User, 2016-2025 (USD Billion)
      • 10.4.9.5. Rest of Asia Pacific Lung cancer therapeutics market revenue, by Distribution Channel, 2016-2025 (USD Billion)
  • 10.5. Latin America
    • 10.5.1. Latin America Lung cancer therapeutics market revenue, by Cancer Type, 2016-2025 (USD Billion)
    • 10.5.2. Latin America Lung cancer therapeutics market revenue, by Treatment, 2016-2025 (USD Billion)
    • 10.5.3. Latin America Lung cancer therapeutics market revenue, by Drug Class, 2016-2025 (USD Billion)
    • 10.5.4. Latin America Lung cancer therapeutics market revenue, by End-User, 2016-2025 (USD Billion)
    • 10.5.5. Latin America Lung cancer therapeutics market revenue, by Distribution Channel, 2016-2025 (USD Billion)
    • 10.5.6. Brazil
      • 10.5.6.1. Brazil Lung cancer therapeutics market revenue, by Cancer Type, 2016-2025 (USD Billion)
      • 10.5.6.2. Brazil Lung cancer therapeutics market revenue, by Treatment, 2016-2025 (USD Billion)
      • 10.5.6.3. Brazil Lung cancer therapeutics market revenue, by Drug Class, 2016-2025 (USD Billion)
      • 10.5.6.4. Brazil Lung cancer therapeutics market revenue, by End-User, 2016-2025 (USD Billion)
      • 10.5.6.5. Brazil Lung cancer therapeutics market revenue, by Distribution Channel, 2016-2025 (USD Billion)
    • 10.5.7. Rest of Latin America
      • 10.5.7.1. Rest of Latin America Lung cancer therapeutics market revenue, by Cancer Type, 2016-2025 (USD Billion)
      • 10.5.7.2. Rest of Latin America Lung cancer therapeutics market revenue, by Treatment, 2016-2025 (USD Billion)
      • 10.5.7.3. Rest of Latin America Lung cancer therapeutics market revenue, by Drug Class, 2016-2025 (USD Billion)
      • 10.5.7.4. Rest of Latin America Lung cancer therapeutics market revenue, by End-User, 2016-2025 (USD Billion)
      • 10.5.7.5. Rest of Latin America Lung cancer therapeutics market revenue, by Distribution Channel, 2016-2025 (USD Billion)
  • 10.6. The Middle East and Africa
    • 10.6.1. The Middle East and Africa Lung cancer therapeutics market revenue, by Cancer Type, 2016-2025 (USD Billion)
    • 10.6.2. The Middle East and Africa Lung cancer therapeutics market revenue, by Treatment, 2016-2025 (USD Billion)
    • 10.6.3. The Middle East and Africa Lung cancer therapeutics market revenue, by Drug Class, 2016-2025 (USD Billion)
    • 10.6.4. The Middle East and Africa Lung cancer therapeutics market revenue, by End-User, 2016-2025 (USD Billion)
    • 10.6.5. The Middle East and Africa Lung cancer therapeutics market revenue, by Distribution Channel, 2016-2025 (USD Billion)
•  
• Chapter 11. Company Profile
  • 11.1. Hoffmann-La Roche
    • 11.1.1. Overview
    • 11.1.2. Financials
    • 11.1.3. Product Portfolio
    • 11.1.4. Business strategy
    • 11.1.5. Recent developments
  • 11.2. Eli Lilly and Company
    • 11.2.1. Overview
    • 11.2.2. Financials
    • 11.2.3. Product Portfolio
    • 11.2.4. Business strategy
    • 11.2.5. Recent developments
  • 11.3. Sanofi-Aventis
    • 11.3.1. Overview
    • 11.3.2. Financials
    • 11.3.3. Product Portfolio
    • 11.3.4. Business strategy
    • 11.3.5. Recent developments
  • 11.4. Pfizer
    • 11.4.1. Overview
    • 11.4.2. Financials
    • 11.4.3. Product Portfolio
    • 11.4.4. Business strategy
    • 11.4.5. Recent developments
  • 11.5. Celgene Corporation
    • 11.5.1. Overview
    • 11.5.2. Financials
    • 11.5.3. Product Portfolio
    • 11.5.4. Business strategy
    • 11.5.5. Recent developments
  • 11.6. GlaxoSmithKline
    • 11.6.1. Overview
    • 11.6.2. Financials
    • 11.6.3. Product Portfolio
    • 11.6.4. Business strategy
    • 11.6.5. Recent developments
  • 11.7. Boehringer Ingelheim
    • 11.7.1. Overview
    • 11.7.2. Financials
    • 11.7.3. Product Portfolio
    • 11.7.4. Business strategy
    • 11.7.5. Recent developments
  • 11.8. Agennix
    • 11.8.1. Overview
    • 11.8.2. Financials
    • 11.8.3. Product Portfolio
    • 11.8.4. Business strategy
    • 11.8.5. Recent developments
  • 11.9. AstraZeneca
    • 11.9.1. Overview
    • 11.9.2. Financials
    • 11.9.3. Product Portfolio
    • 11.9.4. Business strategy
    • 11.9.5. Recent developments
  • 11.10. Merck and company
    • 11.10.1. Overview
    • 11.10.2. Financials
    • 11.10.3. Product Portfolio
    • 11.10.4. Business strategy
    • 11.10.5. Recent developments

Table Of Figures

List of Figures

1. Market research process
2. Market research methodology
3. Global Lung cancer therapeutics market revenue, 2016–2025 (USD Billion)
4. Porter’s Five Forces Analysis
5. Lung cancer therapeutics market attractiveness analysis, by Cancer type
6. Lung cancer therapeutics market attractiveness analysis, by Treatment
7. Lung cancer therapeutics market attractiveness analysis, by Drug Class
8. Lung cancer therapeutics market attractiveness analysis, by End-User
9. Lung cancer therapeutics market attractiveness analysis, by Distribution Channel
10. Lung cancer therapeutics market attractiveness analysis, by Region
11. Company market share analysis, 2018
12. Global Lung cancer therapeutics market share by Cancer type, 2018 and 2025
13. Global Lung cancer therapeutics market revenue for Non-Small Cell Lung Cancer, 2016–2025 (USD Billion)
14. Global Lung cancer therapeutics market revenue for Small Cell Lung Cancer, 2016–2025 (USD Billion)
15. Global Lung cancer therapeutics market share by Treatment, 2018 and 2025
16. Global Lung cancer therapeutics market revenue for Immunotherapy, 2016–2025 (USD Billion)
17. Global Lung cancer therapeutics market revenue for Chemotherapy, 2016–2025 (USD Billion)
18. Global Lung cancer therapeutics market revenue for Targeted Therapy, 2016–2025 (USD Billion)
19. Global Lung cancer therapeutics market revenue for Radiation Therapy, 2016–2025 (USD Billion)
20. Global Lung cancer therapeutics market revenue for Others, 2016–2025 (USD Billion)
21. Global Lung cancer therapeutics market share by Drug Class, 2018 and 2025
22. Global Lung cancer therapeutics market revenue for Antimetabolites, 2016–2025 (USD Billion)
23. Global Lung cancer therapeutics market revenue for Alkylating Agents2016–2025 (USD Billion)
24. Global Lung cancer therapeutics market revenue for Mitotic Inhibitors, 2016–2025 (USD Billion)
25. Global Lung cancer therapeutics market revenue for EGFR Inhibitors, 2016–2025 (USD Billion)
26. Global Lung cancer therapeutics market revenue for Multikinase Inhibitors, 2016–2025 (USD Billion)
27. Global Lung cancer therapeutics market revenue for Others, 2016–2025 (USD Billion)
28. Global Lung cancer therapeutics market share by End-User, 2018 and 2025
29. Global Lung cancer therapeutics market revenue for Hospitals, 2016–2025 (USD Billion)
30. Global Lung cancer therapeutics market revenue for Homecare, 2016–2025 (USD Billion)
31. Global Lung cancer therapeutics market revenue for Specialty Clinics, 2016–2025 (USD Billion)
32. Global Lung cancer therapeutics market revenue for Others, 2016–2025 (USD Billion)
33. Global Lung cancer therapeutics market share by Distribution Channel, 2018 and 2025
34. Global Lung cancer therapeutics market revenue for Retail Pharmacy, 2016–2025 (USD Billion)
35. Global Lung cancer therapeutics market revenue for Hospital Pharmacy, 2016–2025 (USD Billion)
36. Global Lung cancer therapeutics market revenue for Internet, 2016–2025 (USD Billion)
37. Global Lung cancer therapeutics market revenue for Others, 2016–2025 (USD Billion)
38. Global Lung cancer therapeutics market share by Region, 2018 and 2025
39. North America Lung cancer therapeutics market revenue, 2016–2025 (USD Billion)
40. Europe Lung cancer therapeutics market revenue, 2016–2025 (USD Billion)
41. Asia Pacific Lung cancer therapeutics market revenue, 2016–2025 (USD Billion)
42. Latin America Lung cancer therapeutics market revenue, 2016–2025 (USD Billion)
43. The Middle East and Africa Lung cancer therapeutics market revenue, 2016–2025 (USD Billion)

Table Of Tables

List of Tables

1. Lung Cancer Therapeutics Market: Market snapshot
2. Drivers of the Global Lung Cancer Therapeutics Market: Impact analysis
3. Restraints of the Global Lung Cancer Therapeutics Market: Impact analysis
4. North America Lung cancer therapeutics market revenue, by Cancer type, 2016–2025 (USD Billion)
5. North America Lung cancer therapeutics market revenue, by Treatment, 2016–2025 (USD Billion)
6. North America Lung cancer therapeutics market revenue, by Drug Class, 2016–2025 (USD Billion)
7. North America Lung cancer therapeutics market revenue, by End-User, 2016–2025 (USD Billion)
8. North America Lung cancer therapeutics market revenue, by Distribution Channel, 2016–2025 (USD Billion)
9. The U.S. Lung cancer therapeutics market revenue, by Cancer type, 2016–2025 (USD Billion)
10. The U.S. Lung cancer therapeutics market revenue, by Treatment, 2016–2025 (USD Billion)
11. The U.S. Lung cancer therapeutics market revenue, by Drug Class, 2016–2025 (USD Billion)
12. The U.S. Lung cancer therapeutics market revenue, by End-User, 2016–2025 (USD Billion)
13. The U.S. Lung cancer therapeutics market revenue, by Distribution Channel, 2016–2025 (USD Billion)
14. Rest of North America Lung cancer therapeutics market revenue, by Cancer type, 2016–2025 (USD Billion)
15. Rest of North America Lung cancer therapeutics market revenue, by Treatment, 2016–2025 (USD Billion)
16. Rest of North America Lung cancer therapeutics market revenue, by Drug Class, 2016–2025 (USD Billion)
17. Rest of North America Lung cancer therapeutics market revenue, by End-User, 2016–2025 (USD Billion)
18. Rest of North America Lung cancer therapeutics market revenue, by Distribution Channel, 2016–2025 (USD Billion)
19. Europe Lung cancer therapeutics market revenue, by Cancer type, 2016–2025 (USD Billion)
20. Europe Lung cancer therapeutics market revenue, by Treatment, 2016–2025 (USD Billion)
21. Europe Lung cancer therapeutics market revenue, by Drug Class, 2016–2025 (USD Billion)
22. Europe Lung cancer therapeutics market revenue, by End-User, 2016–2025 (USD Billion)
23. Europe Lung cancer therapeutics market revenue, by Distribution Channel, 2016–2025 (USD Billion)
24. Germany Lung cancer therapeutics market revenue, by Cancer type, 2016–2025 (USD Billion)
25. Germany Lung cancer therapeutics market revenue, by Treatment, 2016–2025 (USD Billion)
26. Germany Lung cancer therapeutics market revenue, by Drug Class, 2016–2025 (USD Billion)
27. Germany Lung cancer therapeutics market revenue, by End-User, 2016–2025 (USD Billion)
28. Germany Lung cancer therapeutics market revenue, by Distribution Channel, 2016–2025 (USD Billion)
29. U.K. Lung cancer therapeutics market revenue, by Cancer type, 2016–2025 (USD Billion)
30. U.K. Lung cancer therapeutics market revenue, by Treatment, 2016–2025 (USD Billion)
31. U.K. Lung cancer therapeutics market revenue, by Drug Class, 2016–2025 (USD Billion)
32. U.K. Lung cancer therapeutics market revenue, by End-User, 2016–2025 (USD Billion)
33. U.K. Lung cancer therapeutics market revenue, by Distribution Channel, 2016–2025 (USD Billion)
34. France Lung cancer therapeutics market revenue, by Cancer type, 2016–2025 (USD Billion)
35. France Lung cancer therapeutics market revenue, by Treatment, 2016–2025 (USD Billion)
36. France Lung cancer therapeutics market revenue, by Drug Class, 2016–2025 (USD Billion)
37. France Lung cancer therapeutics market revenue, by End-User, 2016–2025 (USD Billion)
38. France Lung cancer therapeutics market revenue, by Distribution Channel, 2016–2025 (USD Billion)
39. Rest of Europe Lung cancer therapeutics market revenue, by Cancer type, 2016–2025 (USD Billion)
40. Rest of Europe Lung cancer therapeutics market revenue, by Treatment, 2016–2025 (USD Billion)
41. Rest of Europe Lung cancer therapeutics market revenue, by Drug Class, 2016–2025 (USD Billion)
42. Rest of Europe Lung cancer therapeutics market revenue, by End-User, 2016–2025 (USD Billion)
43. Rest of Europe Lung cancer therapeutics market revenue, by Distribution Channel, 2016–2025 (USD Billion)
44. Asia Pacific Lung cancer therapeutics market revenue, by Cancer type, 2016–2025 (USD Billion)
45. Asia Pacific Lung cancer therapeutics market revenue, by Treatment, 2016–2025 (USD Billion)
46. Asia Pacific Lung cancer therapeutics market revenue, by Drug Class, 2016–2025 (USD Billion)
47. Asia Pacific Lung cancer therapeutics market revenue, by End-User, 2016–2025 (USD Billion)
48. Asia Pacific Lung cancer therapeutics market revenue, by Distribution Channel, 2016–2025 (USD Billion)
49. China Lung cancer therapeutics market revenue, by Cancer type, 2016–2025 (USD Billion)
50. China Lung cancer therapeutics market revenue, by Treatment, 2016–2025 (USD Billion)
51. China Lung cancer therapeutics market revenue, by Drug Class, 2016–2025 (USD Billion)
52. China Lung cancer therapeutics market revenue, by End-User, 2016–2025 (USD Billion)
53. China Lung cancer therapeutics market revenue, by Distribution Channel, 2016–2025 (USD Billion)
54. Japan Lung cancer therapeutics market revenue, by Cancer type, 2016–2025 (USD Billion)
55. Japan Lung cancer therapeutics market revenue, by Treatment, 2016–2025 (USD Billion)
56. Japan Lung cancer therapeutics market revenue, by Drug Class, 2016–2025 (USD Billion)
57. Japan Lung cancer therapeutics market revenue, by End-User, 2016–2025 (USD Billion)
58. Japan Lung cancer therapeutics market revenue, by Distribution Channel, 2016–2025 (USD Billion)
59. India Lung cancer therapeutics market revenue, by Cancer type, 2016–2025 (USD Billion)
60. India Lung cancer therapeutics market revenue, by Treatment, 2016–2025 (USD Billion)
61. India Lung cancer therapeutics market revenue, by Drug Class, 2016–2025 (USD Billion)
62. India Lung cancer therapeutics market revenue, by End-User, 2016–2025 (USD Billion)
63. India Lung cancer therapeutics market revenue, by Distribution Channel, 2016–2025 (USD Billion)
64. Rest of Asia Pacific Lung cancer therapeutics market revenue, by Cancer type, 2016–2025 (USD Billion)
65. Rest of Asia Pacific Lung cancer therapeutics market revenue, by Treatment, 2016–2025 (USD Billion)
66. Rest of Asia Pacific Lung cancer therapeutics market revenue, by Drug Class, 2016–2025 (USD Billion)
67. Rest of Asia Pacific Lung cancer therapeutics market revenue, by End-User, 2016–2025 (USD Billion)
68. Rest of Asia Pacific Lung cancer therapeutics market revenue, by Distribution Channel, 2016–2025 (USD Billion)
69. Latin America Lung cancer therapeutics market revenue, by Cancer type, 2016–2025 (USD Billion)
70. Latin America Lung cancer therapeutics market revenue, by Treatment, 2016–2025 (USD Billion)
71. Latin America Lung cancer therapeutics market revenue, by Drug Class, 2016–2025 (USD Billion)
72. Latin America Lung cancer therapeutics market revenue, by End-User, 2016–2025 (USD Billion)
73. Latin America Lung cancer therapeutics market revenue, by Distribution Channel, 2016–2025 (USD Billion)
74. Brazil Lung cancer therapeutics market revenue, by Cancer type, 2016–2025 (USD Billion)
75. Brazil Lung cancer therapeutics market revenue, by Treatment, 2016–2025 (USD Billion)
76. Brazil Lung cancer therapeutics market revenue, by Drug Class, 2016–2025 (USD Billion)
77. Brazil Lung cancer therapeutics market revenue, by End-User, 2016–2025 (USD Billion)
78. Brazil Lung cancer therapeutics market revenue, by Distribution Channel, 2016–2025 (USD Billion)
79. Rest of Latin America Lung cancer therapeutics market revenue, by Cancer type, 2016–2025 (USD Billion)
80. Rest of Latin America Lung cancer therapeutics market revenue, by Treatment, 2016–2025 (USD Billion)
81. Rest of Latin America Lung cancer therapeutics market revenue, by Drug Class, 2016–2025 (USD Billion)
82. Rest of Latin America Lung cancer therapeutics market revenue, by End-User, 2016–2025 (USD Billion)
83. Rest of Latin America Lung cancer therapeutics market revenue, by Distribution Channel, 2016–2025 (USD Billion)
84. The Middle East and Africa Lung cancer therapeutics market revenue, by Cancer type, 2016–2025 (USD Billion)
85. The Middle East and Africa Lung cancer therapeutics market revenue, by Treatment, 2016–2025 (USD Billion)
86. The Middle East and Africa Lung cancer therapeutics market revenue, by Drug Class, 2016–2025 (USD Billion)
87. The Middle East and Africa Lung cancer therapeutics market revenue, by End-User, 2016–2025 (USD Billion)
88. The Middle East and Africa Lung cancer therapeutics market revenue, by Distribution Channel, 2016–2025 (USD Billion)